Back to Results
First PageMeta Content
Medicine / Histoplasmosis / Clinical trial / Coccidioidomycosis / Methadone / Fungal diseases / Health / Biology


Stat NDA Template Draft 2
Add to Reading List

Open Document

File Size: 161,90 KB

Share Result on Facebook

Company

CBER / Allermed Laboratories Inc. / OTHER SPECIAL/SUBGROUP / /

Event

FDA Phase / Person Communication and Meetings / /

IndustryTerm

statistical protocol / /

MedicalCondition

Delayed-type Hypersensitivity / pulmonary coccidioidomycosis / delayed type hypersensitivity / disease / coccidioidomycosis / Pulmonary Histoplasmosis / cellular hypersensitivity / /

Organization

Research office of Biostatistics / FDA / Biostatistics and Epidemiology Division / Food and Drug Administration Center for Biologics Evaluation / DEPARTMENT OF HEALTH AND HUMAN SERVICES / Medical Office / /

Person

Holly Wieland / Douglas Pratt / Ann Schwartz / Cellular Hypersensitiviy / Jon Daugherty / Henry Hsu / Tammy Massie / Estelle Russek-Cohen / A. Dale Horne / Jingyee Kou / Sheldon Morris / /

Position

Mathematical Statistician / PH____ Chief / Project Manager / statistician for this product / /

Product

Candida / S101A / S104-3 / /

PublishedMedium

the Clinical Review / /

Technology

statistical protocol / /

SocialTag